Showing results (1571-1580 of 1,763) with videos related to

Sort By:
Pageof 177
Neuro-Oncology Practice|May 11, 2026
Seizure prophylaxis in glioma surgery (SPRING): A multi-center, unblinded, randomized trialMichael D Jenkinson, Helen Bulbeck, Jackie Burns, et al.
Psychological Medicine|August 3, 2022
The relationship between cognitive clusters and telomere length in bipolar-schizophrenia spectrum disordersCaroline Gurvich, Natalie Thomas, Abdul-Rahman Hudaib, et al.
Nature Communications|February 6, 2024
Repeated upslope biome shifts in Saxifraga during late-Cenozoic climate coolingTom Carruthers, Michelangelo S Moerland, Jana Ebersbach, et al.
Acta Oncologica (Stockholm, Sweden)|February 21, 2023
Sub-regional analysis of the parotid glands: model development for predicting late xerostomia with radiomics features in head and neck cancer patientsThomas Berger, David J Noble, Zhuolin Yang, et al.
Neurology and Therapy|February 13, 2023
Risdiplam in Patients Previously Treated with Other Therapies for Spinal Muscular Atrophy: An Interim Analysis from the JEWELFISH StudyClaudia A Chiriboga, Claudio Bruno, Tina Duong, et al.
Iscience|October 13, 2023
Live-bearing cockroach genome reveals convergent evolutionary mechanisms linked to viviparity in insects and beyondBertrand Fouks, Mark C Harrison, Alina A Mikhailova, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 16, 2021
Characterization of multiple sclerosis neuroinflammation and neurodegeneration with relaxation and diffusion basis spectrum imagingIrene M Vavasour, Peng Sun, Carina Graf, et al.
Psychopharmacology|November 19, 2010
JNJ-39220675, a novel selective histamine H3 receptor antagonist, reduces the abuse-related effects of alcohol in ratsRuggero Galici, Amir H Rezvani, Leah Aluisio, et al.
Multiple Sclerosis and Related Disorders|May 12, 2026
Patient reported outcomes in NMOSD reflect a high disease burden and do not correlate with the EDSSElisa Saeedzadeh, Manav V Vyas, Shristi Sharma, et al.
Pageof 177